Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer DiseasePontus Erickson, Prashanthi Vemuri, Gwendlyn Kollmorgen et al.|JAMA Neurology|2023Cited by 46
The cerebrospinal fluid A‐T+ Alzheimer disease biomarker profile: prevalence and clinical relevancePontus Eriksson, Henrik Zetterberg, Joel Simrén et al.|Alzheimer s & Dementia|2023Cited by 2